Four insights:
1. RenovaCare developed the SkinGun, which sprays a patient’s own stem cells onto burns and wounds to accelerate healing.
2. Dr. Walthall will assist in product development and increasing the use of the company’s technology for conditions such as reconstructive surgery and cosmetics.
3. At Johnson & Johnson, Dr. Walthall served as R&D worldwide director for both tissue regeneration and advanced wound care and later operated as vice president of biologics R&D for Zimmer Biomet.
4. Dr. Walthall also served on the board of wound healing society and on the advisory board for University of California Los Angeles and Atlanta-based Georgia Institute of Technology biomedical departments.
“Dr. Walthall brings us deep expertise in skin and tissue regeneration, worldwide product development, and commercialization of brand new technologies,” said Roger Esteban-Vives, PhD, vice president of research and product development at RenovaCare.
More articles on devices:
Cerapedics expands Colorado HQ — 3 things to know
HSS acquires low-dose orthopedic imaging system — 3 insights
Medtronic secures market-leading position through Titan Spine acquisition, analyst says
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.